Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SelectQuote, Inc. | Director | Common Stock, par value $0.01 per share | 216K | $251K | $1.16 | Nov 14, 2023 | Direct |
Arcellx, Inc. | Director | Common Stock | 0 | $0 | $65.88 | Aug 20, 2024 | Direct |
SelectQuote, Inc. | Director | Restricted Stock Units | 94.9K | Nov 14, 2023 | Direct | ||
Arcellx, Inc. | Director | Stock Option (right to buy) | 64.5K | Aug 20, 2024 | Direct | ||
Sigilon Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | $0.75 | Aug 11, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ACLX | Arcellx, Inc. | Aug 20, 2024 | 3 | -$88.8K | 4 | Aug 22, 2024 | Director |
ACLX | Arcellx, Inc. | Jul 30, 2024 | 4 | -$83K | 4 | Aug 1, 2024 | Director |
ACLX | Arcellx, Inc. | Jul 9, 2024 | 4 | -$75K | 4 | Jul 11, 2024 | Director |
ACLX | Arcellx, Inc. | Jun 27, 2024 | 4 | -$476K | 4 | Jun 28, 2024 | Director |
ACLX | Arcellx, Inc. | May 28, 2024 | 1 | $0 | 4 | Jun 6, 2024 | Director |
SLQT | SelectQuote, Inc. | Nov 14, 2023 | 3 | $0 | 4 | Nov 16, 2023 | Director |
SGTX | Sigilon Therapeutics, Inc. | Aug 11, 2023 | 2 | -$7.95K | 4 | Aug 11, 2023 | Director |
ACLX | Arcellx, Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
SGTX | Sigilon Therapeutics, Inc. | May 19, 2023 | 1 | $0 | 4 | May 22, 2023 | Director |
SLQT | SelectQuote, Inc. | Nov 15, 2022 | 3 | $0 | 4 | Nov 17, 2022 | Director |
SGTX | Sigilon Therapeutics, Inc. | May 26, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
ACLX | Arcellx, Inc. | Feb 3, 2022 | 1 | $0 | 4 | Feb 7, 2022 | Director |
ACLX | Arcellx, Inc. | Feb 3, 2022 | 0 | $0 | 3 | Feb 3, 2022 | Director |
SLQT | SelectQuote, Inc. | Dec 9, 2021 | 2 | $0 | 4 | Dec 9, 2021 | Director |
SLQT | SelectQuote, Inc. | Nov 15, 2021 | 1 | $0 | 4 | Nov 15, 2021 | Director |
IQMD | Intelligent Medicine Acquisition Corp. | Nov 4, 2021 | 0 | $0 | 3 | Nov 4, 2021 | Director |
SGTX | Sigilon Therapeutics, Inc. | Jun 24, 2021 | 1 | $88.6K | 4 | Jun 28, 2021 | Director |